Dr. Nass is responsible for ensuring the scientific and methodological quality of the Hayes evidence products. In previous roles at Hayes, she managed the Hayes Medical Technology Directory and led custom projects for key clients. She has written and edited over 100 health technology assessments or comparative effectiveness reviews.
Prior to joining Hayes, Dr. Nass was a faculty member at the Johns Hopkins University and a postdoctoral fellow at the Food and Drug Administration. She developed plasmid vectors for gene therapy for herpes simplex virus and wound healing, and supported projects on molecular markers in esophageal cancer.
Dr. Nass has a broad understanding of research strategies and methods encompassing the natural and social sciences. Continuing education and certification in public policy and management (University of York, York, United Kingdom), cross-cultural training and management (Heidelberg University of Education, Heidelberg, Germany), systemic and integrative therapy (Psynapse School of Psychotherapy, Paris, France), and computational genomics and executive data science (Johns Hopkins University, Baltimore, USA) complement her professional experience.
Petra Nass, PhD
Executive Scientific Evidence Director, Hayes
How often do you hear about a new and exciting scientific or biomedical advancement and then wonder when it will become available to the millions of Americans who might benefit from it? I’m sure...
Volume and revenue declines have resulted in plummeting margins. In April 2020 margins were a whopping 326 percent below budget. Now, more than ever, healthcare organizations must control costs....
Provider credentialing — required for all hospital privileging and managed care payer enrollments — is a heavily regulated process that can take up to six months to complete. Credentialing includes...
Top 10 Negotiating Strategies
Skilled negotiators are like musical virtuosos. They have an extensive repertoire of tactics from which to draw, and they know when and how to make them a part of their performance. But negotiating healthcare contracts for capital, purchased services, and IT services can test the artistry of even the most masterful negotiator.